Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term clozapine in treatment-resistant schizophrenia
NCT00154258Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2001
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of clozapine in schizophrenia, sponsored by Novartis. Started Apr 2001; status: completed.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00154258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154258.